Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53001

language	eng
Author	Zheng Guoqiao Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany Faculty of Medicine, University of Heidelberg, Heidelberg, Germany Chattopadhyay Subhayan Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany Faculty of Medicine, University of Heidelberg, Heidelberg, Germany Sud Amit Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Sundquist Kristina Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Matsue, Japan Sundquist Jan Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA Center for Community-based Healthcare Research and Education (CoHRE), Department of Functional Pathology, School of Medicine, Shimane University, Matsue, Japan Foersti Asta Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden Houlston Richard S. Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK Division of Molecular Pathology, The Institute of Cancer Research, London, UK Hemminki Akseli Cancer Gene Therapy Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland Hemminki Kari Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany Center for Primary Health Care Research, Lund University, 205 02, Malmö, Sweden
Journal Title	BLOOD CANCER JOURNAL
Volume	9
ISSN	2044-5385
Published Date	2019-03-26
DOI	10.1038/s41408-019-0201-0
PubMed ID	30914634
Publisher	NATURE PUBLISHING GROUP
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	We thank Patrick Reilly for excellent language editing. A. S. is the recipient of Guest Scientist Fellowship of DKFZ. Supported by the Harald Huppert Foundation, the Swedish Research Council, Deutsche Krebshilfe, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Finnish Cancer Organizations, ALF funding from Region Skane, University of Helsinki and Helsinki University Central Hospital and the China Scholarship Council (201606100057, for doctoral student G.Z.).